Assessing intestinal permeability in Crohn’s disease patients using orally administered 52Cr-EDTA
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing intestinal permeability in Crohn’s disease patients using orally administered 52Cr-EDTA
Authors
Keywords
Gastrointestinal tract, Permeability, Excretion, Enterobacteriaceae, Inflammatory bowel disease, Crohn's disease, Inflammatory diseases, Bacterial pathogens
Journal
PLoS One
Volume 14, Issue 2, Pages e0211973
Publisher
Public Library of Science (PLoS)
Online
2019-02-08
DOI
10.1371/journal.pone.0211973
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased fecal calprotectin levels in Crohn’s disease correlate with elevated serum Th1- and Th17-associated cytokines
- (2018) Arno R. Bourgonje et al. PLoS One
- The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation
- (2018) Kaisa Hiippala et al. Nutrients
- Adherent-invasiveEscherichia coliin inflammatory bowel disease
- (2017) Carolina Palmela et al. GUT
- Gut permeability and mucosal inflammation: bad, good or context dependent
- (2017) R Ahmad et al. Mucosal Immunology
- Biomarkers of Inflammation in Inflammatory Bowel Disease
- (2015) Bruce E. Sands GASTROENTEROLOGY
- Methods to determine intestinal permeability and bacterial translocation during liver disease
- (2015) Lirui Wang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Intestinal permeability – a new target for disease prevention and therapy
- (2014) Stephan C Bischoff et al. BMC GASTROENTEROLOGY
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
- (2014) Aleksandar D. Kostic et al. GASTROENTEROLOGY
- Intestinal barrier in inflammatory bowel disease
- (2014) Lena Antoni WORLD JOURNAL OF GASTROENTEROLOGY
- The role and utility of faecal markers in inflammatory bowel disease
- (2014) Frank S. Lehmann et al. Therapeutic Advances in Gastroenterology
- Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring
- (2013) Jose-Manuel Benitez et al. GUT
- Abnormal intestinal permeability in Crohn's disease pathogenesis
- (2012) Christopher W. Teshima et al. Annals of the New York Academy of Sciences
- Crohn's Disease Patients Have More IgG-Binding Fecal Bacteria than Controls
- (2012) Hermie J. M. Harmsen et al. Clinical and Vaccine Immunology
- Importance of disrupted intestinal barrier in inflammatory bowel diseases
- (2010) Saʼad Y. Salim et al. INFLAMMATORY BOWEL DISEASES
- Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease
- (2008) Jennifer Jones et al. Clinical Gastroenterology and Hepatology
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices
- (2007) Jost Langhorst et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings
- (2007) Taina Sipponen et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now